Back to Research Home
INFUInfuSystems Holdings Inc
Health Care · Medical/Dental Instruments · Micro
$13.94−1.41%
As of 23 Oct 2026Mkt cap $242M
Stage 13
WAIT
Fundamentals
45.9/75
Technical
5.4/15
Independent
51.3/90
GCAE viewtechnical state requires waiting rather than entering now
Price
- 1M
- +9.9%
- 3M
- +48.9%
- 6M
- +34.8%
- 1Y
- +42.4%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 34.0xHist median 37.7x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 12.8x
- FCF yield
- 7.8%
Quality
- ROIC
- 9.6%
- Operating margin
- 5.1%
- FCF margin
- 16.6%
- Current ratio
- 1.8x
Growth
- Revenue growth
- +6.4%Latest FY YoY
- Revenue CAGR
- +8.8%
- EPS CAGR
- +50.8%
- FCF CAGR
- +8.3%
Capital
- Share-count trend
- −1.3%3Y annualised
- Net debt
- $17M0.7x OCF
Annual trend
- CAGR 2021–2025
- +8.8%
- Latest · 2025
- $0B
- YoY
- +6.4%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
technical state requires waiting rather than entering now
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-03
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded